Drug Shortage Report for GD-AMLODIPINE/ATORVASTATIN

Last updated on 2017-08-04 History
Report ID 16832
Drug Identification Number 02362759
Brand name GD-AMLODIPINE/ATORVASTATIN
Common or Proper name GD-Amlodipine/Atorvastatin
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Active Ingredient(s) AMLODIPINE ATORVASTATIN
Strength(s) 5MG 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90s
ATC code C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-07-19
Actual start date
Estimated end date 2017-08-03
Actual end date 2017-08-03
Shortage status Resolved
Updated date 2017-08-04
Company comments Resolved August 3, 2017
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-08-04 English Compare
v7 2017-08-03 French Compare
v6 2017-08-03 English Compare
v5 2017-08-03 English Compare
v4 2017-07-24 French Compare
v3 2017-07-24 English Compare
v2 2017-07-24 French Compare
v1 2017-07-24 English Compare